Latest DRC News
- Details
Editor's Note: The information published in this story is accurate at the time of publication. Always refer to uab.edu/uabunited for UAB's current guidelines and recommendations relating to COVID-19.
Media contacts: Jeff Hansen and Savannah Koplon
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.
- Details
Take a look back at a critical conversation about diabetes with Dr. Anath Shalev and Dr. Fernando Ovalle during Novel Approaches to Diabetes.
- Details
Type 1 diabetes, or T1D, results from the autoimmune destruction of the insulin-producing cells of the pancreas. People with T1D require exogenous insulin and suffer swings in the levels of glucose in the blood that impact life expectancy and increase risks of cardiovascular disease, neuropathies and kidney failure.
- Details
Type 1 diabetes, or T1D, is an autoimmune disease in which the body’s immune cells — led by inflammatory macrophages — attack and destroy the beta cells of the pancreas that produce insulin.
- Details
A new study, published in Nutrition and Metabolism, from researchers with the University of Alabama at Birmingham’s Nutrition Obesity Research Center observed improvements in body composition, fat distribution and metabolic health in response to an eight-week, very low-carbohydrate diet.
- Details
The University of Alabama at Birmingham and Southern Research have discovered a new drug candidate that offers a major advance in the treatment for diabetes.
- Details
A new study from researchers with the University of Alabama at Birmingham’s Department of Nutrition Sciences suggests consumption of a moderately carbohydrate-restricted diet may result in decreased fatty liver tissue, as well as improvements in body composition and insulin resistance, in adolescents with non-alcoholic fatty liver disease.
- Details
UAB is a unique place, says Barbara Gower, Ph.D., professor and vice chair for Research in the School of Health Professions Department of Nutrition Sciences. But not just because the university brought in nearly $300 million in NIH funding this past year, or because our orthopaedic surgeons offer total knee replacements without an overnight hospital stay for some patients.
- Details
Valene Garr Barry, a graduate student pursuing a doctoral degree in the UAB School of Health Professions' Department of Nutrition Sciences and a pre-doctoral fellow of the Nutrition Obesity Research Center, was honored with the President’s Diversity Champion Award Feb. 21. The annual award recognizes employees, students and organizations that have helped create a more culturally diverse, inclusive university community through their achievements.